Top section
Top section
Both tranches price at the investor-friendly end as cloud company raises to fund expansion
Never mind that your desk had a great year, writes Craig. When it comes to getting paid, the future makes a stronger argument than the past
Top 25 shareholders and new investors participate in previously delayed offering, but some shares left over after subscriptions closed
More articles
More articles
More articles
-
Qualitas Medical Group is preparing to launch an IPO of around S$150m ($114.4m) on the Singapore Exchange, said a banker on the deal. -
Lemon Tree Hotels has kicked off bookbuilding for a potential Rp10.4bn ($159.9m) IPO, after placing nearly a third of the shares with anchor investors.
-
China Zheshang Bank has raised HK$3.6bn ($464.2m) from a placement of new H-shares, its first issue since listing in Hong Kong two years ago.
-
The strong momentum of the IPO market has been hindered this week as markets subject are buffeted by heightened geopolitical volatility in the wake of the Cambridge Analytica scandal and of new US trade tariffs.
-
Aviva bowed to pressure on Friday and announced that it would not redeem its preference shares after all. It also said that if it reconsidered, it would take into account the market value of the shares.
-
Pfizer’s consumer healthcare business has gone from being the belle of the ball to the last one left on the dancefloor on Friday, after GlaxoSmithKline joined Reckitt Benckiser in pulling out of a potential acquisition of the unit.
Sub-sections
shared comment list
